NDC | Strength | Package Size | Dosage Form | Brand Reference | Image | Details | Packing Insert | Medication Guide |
---|---|---|---|---|---|---|---|---|
82619-103-01 | 0.625 mg + 1.25 mg | 15 mm | Tablets | Covaryx | View Details | |||
82619-104-01 | 1.25 mg+ 2.5 mg | 15 mm | Tablets | Covaryx | View Details |
NDC | Strength | Package Size | Dosage Form | Brand Reference | Image | Details | Packing Insert | Medication Guide |
---|---|---|---|---|---|---|---|---|
82619-113-01 | 4 mg (30’s) | 15.8 mm | Capsules | RAPAFLO | View Details | |||
82619-114-01 | 8 mg (30’s) | 19.33 mm | Capsules | RAPAFLO | View Details | |||
82619-114-02 | 8 mg (90’s) | 19.33 mm | Capsules | RAPAFLO | View Details |
NDC | Strength | Package Size | Dosage Form | Brand Reference | Image | Details | Packing Insert | Medication Guide |
---|---|---|---|---|---|---|---|---|
82619-111-04/05 | 5 mg | 10 x 4 mm | Tablets | MAXALT | View Details | |||
82619-112-04/05 | 10 mg | 12 X 4.2 mm | Tablets | MAXALT | View Details |
NDC | Strength | Package Size | Dosage Form | Brand Reference | Image | Details | Packing Insert | Medication Guide |
---|---|---|---|---|---|---|---|---|
82619-101-01 | 40 mg | 8.0 mm | Tablets | FENOGLIDE | View Details | |||
82619-102-01 | 120 mg | 17.75 x 7.65 mm | Tablets | FENOGLIDE | View Details |
Strength | 0.625 mg + 1.25 mg |
Size | 15 mm |
NDC | 82619-103-01 |
GTN | 382619103014 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | Covaryx |
Case Qty | 12 |
Case Wt (lbs) | 2 lbs |
Case dimension (Inches) | 7.25×3.375×7.33 |
Bottle Size (inches) | 1.75×3.25×1.75 |
Bottle Wt (lbs) | 0.167 lbs |
Product Shelf life | 24 months |
Shape | Oval Shaped |
Colour | Dark Green |
Imprint/embossing | 829/E |
Therapeutic Class | Hormone |
Indication | Hormone Replacement |
Active Ingredients | Esterified Estrogen and Methytestosterone |
Contains Gluten | No |
Contains Soy | No |
Contains Lactose | Yes |
Contains Artificial sweeteners | No |
Contains Dye | Yes |
Strength | 1.25 mg+ 2.5 mg |
Size | 15 mm |
NDC | 82619-104-01 |
GTN | 382629104011 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | Covaryx |
Case Qty | 12 |
Case Wt (lbs) | 2 lbs |
Case dimension (Inches) | 7.25×3.375×7.33 |
Bottle Size (inches) | 1.75×3.25×1.75 |
Bottle Wt (lbs) | 0.167 lbs |
Product Shelf life | 24 months |
Shape | Oval Shaped |
Colour | Light Green |
Imprint/embossing | 830/E |
Therapeutic Class | Hormone |
Indication | Hormone Replacement |
Active Ingredients | Esterified Estrogen and Methytestosterone |
Contains Gluten | No |
Contains Soy | No |
Contains Lactose | Yes |
Contains Artificial sweeteners | No |
Contains dye | Yes |
Product Name | Silodosin Capsule USP |
Strength | 4 mg |
Size | 15.8 mm |
NDC | 82619-113-01 |
GTN | 382619113013 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | RAPAFLO |
Case Qty | 140 |
Case Wt (lbs) | 11.82 |
Case dimension (Inches) | 15.94 x 11.22 x 7.68 |
Bottle Size (inches) | 1.57 x 1.57 x 2.95 |
Bottle Wt (lbs) | 0.05 |
Product Shelf life | 24 months |
Shape | Capsule |
Colour | White opaque cap |
Imprint/embossing | Cap 479 Body 4 |
Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
Indication | Benign prostatic hyperplasia |
Active Ingredients | Silodosin |
Contains Gluten | No |
Contains Soy | No |
Contains Lactose | No |
Contains Artificial sweeteners | No |
Contains dye | No |
Product Name | Silodosin Capsule USP |
Strength | 8 mg |
Size | 19.33 mm |
NDC | 82619-114-01 |
GTN | 382619114010 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | RAPAFLO |
Case Qty | 140 |
Case Wt (lbs) | 13.45 |
Case dimension (Inches) | 15.94 x 11.22 x 7.68 |
Bottle Size (inches) | 1.57 x 1.57 x 2.95 |
Bottle Wt (lbs) | 0.06 |
Product Shelf life | 24 months |
Shape | Capsule |
Colour | White opaque cap |
Imprint/embossing | Cap 480 Body 8 |
Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
Indication | Benign prostatic hyperplasia |
Active Ingredients | Silodosin |
Contains Gluten | No |
Contains Soy | No |
Contains Lactose | No |
Contains Artificial sweeteners | No |
Contains dye | No |
Product Name | Silodosin Capsule USP |
Strength | 8 mg |
Size | 19.33 mm |
NDC | 82619-114-02 |
GTN | 382619114027 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | RAPAFLO |
Case Qty | 80 |
Case Wt (lbs) | 13.49 |
Case dimension (Inches) | 15.35 x 9.64 x 9.25 |
Bottle Size (inches) | 1.89 x 1.89 x3.78 |
Bottle Wt (lbs) | 0.12 |
Product Shelf life | 24 months |
Shape | Capsule |
Colour | White opaque cap |
Imprint/embossing | Cap 480 Body 8 |
Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
Indication | Benign prostatic hyperplasia |
Active Ingredients | Silodosin |
Contains Gluten | No |
Contains Soy | No |
Contains Lactose | No |
Contains Artificial sweeteners | No |
Contains dye | No |
Product Details | 12’s pack | 18’s pack |
Product Name | Rizatriptan Benzoate Tablets USP 5 mg | Rizatriptan Benzoate Tablets USP 5 mg |
Strength | 5 mg | 5 mg |
Size | 10 x 4 mm | 10 x 4 mm |
NDC | 82619-111-04 | 82619-111-05 |
GTN | 382619111040 | 382619111057 |
OTC/Rx | RX | RX |
TE Code | AB | AB |
Ref Brand | MAXALT | MAXALT |
Case Qty | 225 | 180 |
Case Wt (lbs) | 11.2 | 11.2 |
Case dimension (Inches) | 11.89 x 10.32 x 13.50 | 11.89 x 10.32 x 13.50 |
Bottle Size (inches) | 4.02 x 0.79 x 1.89 | 4.02 x 0.79 x 1.89 |
Bottle Wt (lbs) | 0.04 | 0.04 |
Product Shelf life | 24 months | 24 months |
Shape | Capsule | Capsule |
Colour | Pale Pink | Pale Pink |
Imprint/embossing | 388 | 388 |
Therapeutic Class | Antimigraine | Antimigraine |
Indication | For acute treatment of Migraine | For acute treatment of Migraine |
Active Ingredients | Rizatriptan Benzoate | Rizatriptan Benzoate |
Contains Gluten | No | No |
Contains Soy | No | No |
Contains Lactose | Yes | Yes |
Contains Artificial sweeteners | No | No |
Contains dye | No | No |
Product Details | 12’s pack | 18’s pack |
Product Name | Rizatriptan Benzoate Tablets USP 10 mg | Rizatriptan Benzoate Tablets USP 10 mg |
Strength | 10 mg | 10 mg |
Size | 12 X 4.2 mm | 12 X 4.2 mm |
NDC | 82619-112-04 | 82619-112-05 |
GTN | 382619112047 | 382619112054 |
OTC/Rx | RX | RX |
TE Code | AB | AB |
Ref Brand | MAXALT | MAXALT |
Case Qty | 225 | 180 |
Case Wt (lbs) | 11.2 | 11.2 |
Case dimension (Inches) | 11.89 x 10.32 x 13.50 | 11.89 x 10.32 x 13.50 |
Bottle Size (inches) | 4.02 x 0.79 x 1.89 | 4.02 x 0.79 x 1.89 |
Bottle Wt (lbs) | 0.04 | 0.04 |
Product Shelf life | 24 months | 24 months |
Shape | Capsule | Capsule |
Colour | Pale Pink | Pale Pink |
Imprint/embossing | 389 | 389 |
Therapeutic Class | Antimigraine | Antimigraine |
Indication | For acute treatment of Migraine | For acute treatment of Migraine |
Active Ingredients | Rizatriptan Benzoate | Rizatriptan Benzoate |
Contains Gluten | No | No |
Contains Soy | No | No |
Contains Lactose | Yes | Yes |
Contains Artificial sweeteners | No | No |
Contains dye | No | No |
Product Name | Fenofibrate Tablets |
Strength | 40 mg |
Size | 8.0 mm |
NDC | 82619-101-01 |
GTN | 382619101010 |
OTC/Rx | RX |
TE Code | BX |
Ref Brand | FENOGLIDE |
Case Qty | 12 |
Case Wt (lbs) | 1.52 |
Case dimension (Inches) | 6.64 x 5.12 x 4.20 |
Bottle Size (inches) | 1.60 x 1.60 x 3.60 |
Bottle Wt (lbs) | 0.099 |
Product Shelf life | 24 months |
Shape | Round shape |
Colour | White to off white |
Imprint/embossing | 293 |
Therapeutic Class | Primary Hypercholesterolemia, Hypertriglyceridemia |
Indication | Hypercholesterolemia |
Active Ingredients | Fenofibrate |
Contains Gluten | No |
Contains Soy | No |
Contains Lactose | Yes |
Contains Artificial sweeteners | No |
Contains dye | No |
Product Name | Fenofibrate Tablets |
Strength | 120 mg |
Size | 17.75 x 7.65 mm |
NDC | 82619-102-01 |
GTN | 382619102017 |
OTC/Rx | RX |
TE Code | BX |
Ref Brand | FENOGLIDE |
Case Qty | 12 |
Case Wt (lbs) | 2.89 |
Case dimension (Inches) | 8 x 6.20 x 5 |
Bottle Size (inches) | 1.92 x 1.92 x 4.40 |
Bottle Wt (lbs) | 0.2 |
Product Shelf life | 24 months |
Shape | Oval shaped |
Colour | White to off white |
Imprint/embossing | 294 |
Therapeutic Class | Primary Hypercholesterolemia, Hypertriglyceridemia |
Indication | Hypercholesterolemia |
Active Ingredients | Fenofibrate |
Contains Gluten | No |
Contains Soy | No |
Contains Lactose | Yes |
Contains Artificial sweeteners | No |
Contains dye | No |
ANDA # | Product | Dosage | Strengths |
---|---|---|---|
A202047 | Rizatriptan Benzoate | Tablets | 5 mg and 10 mg |
A213423 | Pregabalin | Capsules | 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200mg, 225 mg and 300mg |
Strength | 120 mg |
NDC | 82619-102-01 |
GTN | 382619102017 |
OTC/Rx | RX |
TE Code | BX |
Ref Brand | FENOGLIDE |
Therapeutic Class | Primary Hypercholesterolemia, Hypertriglyceridemia |
Strength | 40 mg |
NDC | 82619-101-01 |
GTN | 382619101010 |
OTC/Rx | RX |
TE Code | BX |
Ref Brand | FENOGLIDE |
Therapeutic Class | Primary Hypercholesterolemia, Hypertriglyceridemia |
Product Details | 12's Pack | 18's Pack |
---|---|---|
Strength | 10 mg | 10 mg |
NDC | 82619-112-04 | 82619-112-05 |
GTN | 382619112047 | 382619112054 |
OTC/Rx | RX | RX |
TE Code | AB | AB |
Ref Brand | MAXALT | MAXALT |
Therapeutic Class | Antimigraine | Antimigraine |
Product Details | 12's Pack | 18's Pack |
---|---|---|
Strength | 5 mg | 5 mg |
NDC | 82619-111-04 | 82619-111-05 |
GTN | 382619111040 | 382619111057 |
OTC/Rx | RX | RX |
TE Code | AB | AB |
Ref Brand | MAXALT | MAXALT |
Therapeutic Class | Antimigraine | Antimigraine |
Strength | 8 mg |
NDC | 82619-114-02 |
GTN | 382619114027 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | RAPAFLO |
Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
Strength | 8 mg |
NDC | 82619-114-01 |
GTN | 382619114010 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | RAPAFLO |
Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
Strength | 4 mg |
NDC | 82619-113-01 |
GTN | 382619113013 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | RAPAFLO |
Therapeutic Class | Alpha‑1 adrenergic receptor antagonist |
Strength | 1.25 mg+ 2.5 mg |
NDC | 82619-104-01 |
GTN | 382629104011 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | Covaryx |
Therapeutic Class | Hormone |
Strength | 0.625 mg + 1.25 mg |
NDC | 82619-103-01 |
GTN | 382619103014 |
OTC/Rx | RX |
TE Code | AB |
Ref Brand | Covaryx |
Case Qty | 12 |
Therapeutic Class | Hormone |